Skip to main content
HR 1660 115th Congress House International Affairs Child health Congressional oversight Drug therapy Foreign aid and international relief HIV/AIDS Health programs administration and funding Health promotion and preventive care Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Medical tests and diagnostic methods Product development and innovation Public-private cooperation U.S. Agency for International Development (USAID) Women's health World health

Global Health Innovation Act of 2017

Introduced: March 21, 2017 See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 22 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jan 3, 2019
Became Public Law No: 115-411.
Jan 3, 2019
Signed by President.
Dec 27, 2018
Presented to President.
Dec 21, 2018
Message on Senate action sent to the House.
Dec 20, 2018
Passed Senate without amendment by Unanimous Consent. (consideration: CR S8002)
Dec 20, 2018
Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.(consideration: CR S8002)
Mar 22, 2018
Placed on Senate Legislative Calendar under General Orders. Calendar No. 364.
Mar 22, 2018
Committee on Foreign Relations. Reported by Senator Corker without amendment. Without written report.
Mar 20, 2018
Committee on Foreign Relations. Ordered to be reported without amendment favorably.
Jan 19, 2018
Received in the Senate and Read twice and referred to the Committee on Foreign Relations.
Jan 18, 2018
Motion to reconsider laid on the table Agreed to without objection.
Jan 18, 2018
On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34). (text: CR 1/17/2018 H439)
Jan 18, 2018
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 423 - 3 (Roll no. 34).(text: CR 1/17/2018 H439)
Jan 18, 2018
Considered as unfinished business. (consideration: CR H538-539)
Jan 17, 2018
At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.
Jan 17, 2018
DEBATE - The House proceeded with forty minutes of debate on H.R. 1660.
Jan 17, 2018
Considered under suspension of the rules. (consideration: CR H439-440)
Jan 17, 2018
Mr. Royce (CA) moved to suspend the rules and pass the bill.
Sep 28, 2017
Committee Consideration and Mark-up Session Held.
Sep 28, 2017
Ordered to be Reported by Voice Vote.
Mar 21, 2017
Referred to the House Committee on Foreign Affairs.
Mar 21, 2017
Introduced in House
 Votes taken on this bill 1
DateChamberWhat was voted onResultYes–No
Jan 19, 2018 House · vote #34 On Motion to Suspend the Rules and Pass Passed 423–3 See who voted →
 Plain-English summary Congressional Research Service

Global Health Innovation Act of 2017

This bill directs the U.S. Agency for International Development (USAID) to report to Congress, annually for four years, on the development and use of global health innovations in USAID programs, projects, and activities.

Such reports shall include topics including: (1) USAID's health product development goals and progress towards their achievement; (2) how innovation has advanced USAID's commitments to achieving an HIV/AIDS-free generation, ending preventable child and maternal deaths, and protecting communities from infectious diseases; (3) how USAID, alone and in partnerships, is leveraging U.S. investments to achieve greater health innovation; and (4) coordination with other federal departments.

What's happening now January 3, 2019

Became Public Law No: 115-411.

 Committees of jurisdiction 2
 Cosponsors 9
All 9 Democratic 7 Republican 2